Identifying reliable biomarkers of aging is a major goal in geroscience.While the first generation of epigenetic biomarkers of aging were developed using chronological age as a surrogate for biological age, we hypothesized that incorporation of composite clinical measures of phenotypic age that capture differences in lifespan and healthspan may identify novel CpGs and facilitate the development of a more powerful epigenetic biomarker of

An epigenetic biomarker of aging for lifespan and healthspan